PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vanderbilt-Ingram Cancer Center, Nashville, TN.\', \'Division of Hematology and Oncology, Oregon Health and Science University, Knight Cancer Institute, Portland, OR.\', \'University of Texas MD Anderson Cancer Center Pharmacy Clinical Programs, Houston, TX.\', \'Intermountain Healthcare, Salt Lake, UT.\', \'Moffitt Cancer Center, Tampa, FL.\', \'Cleveland Clinic Taussig Cancer Center, Cleveland, OH.\', \'New York University Langone Health, New York, NY.\', \'Winthrop P. Rockefeller Cancer Institute, University of Arkansas, Little Rock, AR.\', \'Kaiser Permanente, Los Angeles Cancer Clinic, Los Angeles, CA.\', \'Moores Cancer Center, UC San Diego Health, La Jolla, CA.\', \'University of Cincinnati Health Barrett Cancer Center, Cincinnati, OH.\', \'Karmanos Cancer Center, Detroit, MI.\', \'University of Texas MD Anderson Cancer Center, Houston, TX.\', \'Virginia Mason Cancer Center, Seattle, WA.\', \'Smilow Cancer Center, Yale School of Medicine, New Haven, CT.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1200/OP.20.00701
?:hasPublicationType
?:journal
  • JCO oncology practice
is ?:pmid of
?:pmid
?:pmid
  • 33534616
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33534616>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33534616>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all